IS5349A - Blöndur, samstæður og aðferðir til að hindra sjúkdóma í heilaæðum og taugum og vöðva-höfuðverki - Google Patents

Blöndur, samstæður og aðferðir til að hindra sjúkdóma í heilaæðum og taugum og vöðva-höfuðverki

Info

Publication number
IS5349A
IS5349A IS5349A IS5349A IS5349A IS 5349 A IS5349 A IS 5349A IS 5349 A IS5349 A IS 5349A IS 5349 A IS5349 A IS 5349A IS 5349 A IS5349 A IS 5349A
Authority
IS
Iceland
Prior art keywords
compilations
nervous
mixtures
methods
headaches
Prior art date
Application number
IS5349A
Other languages
English (en)
Inventor
H. Levin Bruce
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of IS5349A publication Critical patent/IS5349A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IS5349A 1997-07-21 2000-01-18 Blöndur, samstæður og aðferðir til að hindra sjúkdóma í heilaæðum og taugum og vöðva-höfuðverki IS5349A (is)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US89719297A 1997-07-21 1997-07-21
US7284598P 1998-01-28 1998-01-28
US8455998P 1998-05-06 1998-05-06
PCT/US1998/014870 WO1999003473A1 (en) 1997-07-21 1998-07-17 Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches

Publications (1)

Publication Number Publication Date
IS5349A true IS5349A (is) 2000-01-18

Family

ID=27372174

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5349A IS5349A (is) 1997-07-21 2000-01-18 Blöndur, samstæður og aðferðir til að hindra sjúkdóma í heilaæðum og taugum og vöðva-höfuðverki

Country Status (20)

Country Link
EP (1) EP0999839B1 (is)
JP (1) JP4521117B2 (is)
KR (1) KR20010022041A (is)
CN (1) CN1267219A (is)
AR (1) AR013240A1 (is)
AT (1) ATE269702T1 (is)
AU (1) AU8574398A (is)
BR (1) BR9810773A (is)
CA (1) CA2297097C (is)
DE (1) DE69824730T2 (is)
EE (1) EE200000050A (is)
HU (1) HUP0003953A3 (is)
ID (1) ID24903A (is)
IL (2) IL134087A0 (is)
IS (1) IS5349A (is)
NO (1) NO20000293L (is)
PL (1) PL338176A1 (is)
SK (1) SK187899A3 (is)
TR (1) TR200000149T2 (is)
WO (1) WO1999003473A1 (is)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9704349D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use
JP4632499B2 (ja) * 1999-08-26 2011-02-16 武田薬品工業株式会社 鼻粘膜付着マトリックス
WO2001043733A2 (en) * 1999-12-15 2001-06-21 Levin Bruce H Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation
GB9930083D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Medicaments
US7146209B2 (en) 2000-05-08 2006-12-05 Brainsgate, Ltd. Stimulation for treating eye pathologies
US7640062B2 (en) 2000-05-08 2009-12-29 Brainsgate Ltd. Methods and systems for management of alzheimer's disease
WO2001085094A2 (en) 2000-05-08 2001-11-15 Brainsgate Ltd. Method and apparatus for stimulating the sphenopalatine ganglion to modify properties of the bbb and cerebral blood flow
US6853858B2 (en) 2000-05-08 2005-02-08 Brainsgate, Ltd. Administration of anti-inflammatory drugs into the central nervous system
US7117033B2 (en) 2000-05-08 2006-10-03 Brainsgate, Ltd. Stimulation for acute conditions
US7561919B2 (en) 2002-11-14 2009-07-14 Brainsgate Ltd. SPG stimulation via the greater palatine canal
JP2006515999A (ja) 2002-11-14 2006-06-15 ブレインズゲート リミティド 刺激のための外科用ツール及び技法
US7769461B2 (en) 2003-12-19 2010-08-03 Boston Scientific Neuromodulation Corporation Skull-mounted electrical stimulation system and method for treating patients
US9233245B2 (en) 2004-02-20 2016-01-12 Brainsgate Ltd. SPG stimulation
US8055347B2 (en) 2005-08-19 2011-11-08 Brainsgate Ltd. Stimulation for treating brain events and other conditions
US8010189B2 (en) 2004-02-20 2011-08-30 Brainsgate Ltd. SPG stimulation for treating complications of subarachnoid hemorrhage
JP4843824B2 (ja) 2004-08-18 2011-12-21 株式会社 メドレックス 外用剤
MX2011000862A (es) * 2008-07-21 2011-03-15 Otonomy Inc Composiciones antimicrobianas de liberacion controlada y metodos para el tratamiento de trastornos oticos.
DE102008037682A1 (de) 2008-08-14 2010-04-08 Strackharn, Klaus, Dr.med. Verwendung äquipotenter Dosierungen von Lokalanästetika oder Derivaten davon zur Therapie chronischer Schmerzen
CA2885749A1 (en) 2012-09-28 2014-04-03 St. Renatus, Llc Pharmaceutical composition comprising benzyl alcohol for the treatment of migraines
CN103432378A (zh) * 2013-08-15 2013-12-11 吕清华 一种治疗神经血管性头痛的中药
EP2878335B1 (en) 2013-11-10 2018-01-03 Brainsgate Ltd. Implant and delivery system for neural stimulator
US10271907B2 (en) 2015-05-13 2019-04-30 Brainsgate Ltd. Implant and delivery system for neural stimulator
EP3897603A4 (en) * 2018-12-19 2022-09-14 Grace Therapeutics Inc. THERAPEUTIC COMPOSITION OF INTRANASAL LIDOCAINE
US20220096452A1 (en) * 2019-01-22 2022-03-31 Icm (Institut Du Cerveau Et De La Moelle Épinière) Local anesthetic for the treatment of neurological symptoms resulting from brain dysfunctions
GB2628149A (en) * 2023-03-16 2024-09-18 Lee Nathaniel Wurie Nasal spray for performing sphenopalatine ganglion block

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321061D0 (en) * 1993-10-13 1993-12-01 Chiroscience Ltd Analgestic agent and its use
DE19524691A1 (de) * 1995-07-06 1997-01-09 Liedtke Pharmed Gmbh Methode und Zusammensetzung einer topischen Therapie von Innenohr und Labyrinth-Symptomen
DE19526019A1 (de) * 1995-07-17 1997-01-23 Liedtke Pharmed Gmbh Methode und Zusammensetzung einer topischen Therapie von Kopfschmerzen
BE1009851A3 (fr) * 1996-01-11 1997-10-07 Thiebauld Charles Marie Composition pharmaceutique pour le traitement des cephalees et son utilisation.
GB2315673A (en) * 1996-08-01 1998-02-11 Merck & Co Inc Treatment of migraine
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
GB9704349D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use

Also Published As

Publication number Publication date
NO20000293L (no) 2000-03-20
CA2297097C (en) 2009-04-07
HUP0003953A1 (hu) 2002-01-28
IL134087A (en) 2006-10-31
PL338176A1 (en) 2000-10-09
TR200000149T2 (tr) 2000-05-22
BR9810773A (pt) 2000-09-19
CN1267219A (zh) 2000-09-20
ATE269702T1 (de) 2004-07-15
NO20000293D0 (no) 2000-01-20
JP4521117B2 (ja) 2010-08-11
EP0999839B1 (en) 2004-06-23
SK187899A3 (en) 2000-12-11
CA2297097A1 (en) 1999-01-28
AU8574398A (en) 1999-02-10
IL134087A0 (en) 2001-04-30
JP2001513483A (ja) 2001-09-04
HUP0003953A3 (en) 2002-02-28
DE69824730T2 (de) 2005-07-14
WO1999003473A1 (en) 1999-01-28
EP0999839A1 (en) 2000-05-17
KR20010022041A (ko) 2001-03-15
AR013240A1 (es) 2000-12-13
ID24903A (id) 2000-08-31
EE200000050A (et) 2000-10-16
DE69824730D1 (de) 2004-07-29

Similar Documents

Publication Publication Date Title
IS5349A (is) Blöndur, samstæður og aðferðir til að hindra sjúkdóma í heilaæðum og taugum og vöðva-höfuðverki
NO20010309L (no) Ikke-peptidiske midler for inhibering av gonatropinfrigjörende hormoner, samt fremgangsmåter og mellomprodukter til fremstilling derav
ZA976374B (en) Exercise methods and apparatus.
ZA976375B (en) Exercise methods and apparatus.
DK0895872T3 (da) Apparat til bogindbinding
EP1157275A4 (en) NOVEL TRANSDUCTION MOLECULES AND METHODS OF USING THE SAME
DK0942942T3 (da) Epoxid-amin-dendrimerer, deres fremstilling og anvendelse
DK1003383T3 (da) Smagsforstærkende N-ethyl-p-menthan-3-carboxamidindeholdende forbindelser og fremgangsmåde til fremstilling og anvendelse deraf
DK1060591T3 (da) Pseudo-vilkårlig sekvensgenerator og tilhørende fremgangsmåde
KR980000801U (ko) 경혈 지압구
NO970634L (no) Blandinger og fremgangsmåter for behandling av hydrokarbon-inneholdende formasjoner
IL122253A0 (en) Rehabilitation exercise apparatus
NO20003268D0 (no) Hyperhydrert kitikolin, fremgangsmÕte og anvendelse
ID20281A (id) Blok rantai yang dioperasikan dengan tangan
GB2331904B (en) Improvements to exercise apparatus
IS6428A (is) Aðferð og blanda til að meðhöndla sársauka
DK109996A (da) Kombineret overtræk og regnslag til knallerter og cykler
GB2394191B (en) Chromatography methods and chromatography apparatus
GB2370959B (en) Improvements to exercise apparatus
SK1756U (sk) Rehabilitačný posteľový bicykel
NO974627D0 (no) Utstyr til bruk for avlastning av muskler
BR7601274U (pt) Disposiçoes construtivas introduzidas em boné
ES1033107Y (es) Aparato gimnastico.
BR7600360U (pt) Disposição introduzida em halteres
IT242187Y1 (it) Valigia per motoveicoli